AbbVie Sets $1.55 Quarterly Dividend, Piper Sandler Ups Target by Mark Eisenberg 22.06.2024 AbbVie sets quarterly dividend at $1.55 per share, showcasing financial health and strategic growth. Recent acquisitions bolster positive outlook.
2 Monster Growth Stocks with Huge Potential in 2024 by Mark Eisenberg 08.04.2024 Consider investing in AbbVie and e.l.f., two names with significant growth potential in 2024. AbbVie shines as a quality business ...
NextCure, Inc.: Promising Growth Potential or Risky Investment? by Mark Eisenberg 28.03.2024 NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.
Vaccinex Expands Access to ActivMAb Antigen Virus Technology by Lilu Anderson 21.02.2024 ActivMAb's new "Antigen Virus" application complements drug discovery strategies for complex protein targets, according to Vaccinex CEO. Ongoing partnerships can ...